Abstract PCT No. PCT/JP89/00726 Sec. 371 Date Mar. 21, 1990 Sec. 102(e) Date Mar. 21, 1990 PCT Filed Jul. 20, 1989 PCT Pub. No. WO90/00892 PCT Pub. Date Feb. 8, 1990.This invention relates to a hardening material for medical and dental use which is composed of a powder of calcium phosphate and a hardening liquid. A subject of the present invention is to provide a hardening material wherein a calcified hard tissue analogous to body hard tissue capable of making chemically a sufficient bond with body hard tissue is formed in a body within relatively short time passage. To attain the above-described objective, the hardening material for medical and dental use relating to the present invention is composed of a calcium phosphate powder and a hardening liquid and also of at least either one of collagen and/or collagen derivatives in a state of powder or solution, and the calcium phosphate powder contains a powder of alpha -tricalcium phosphate [ alpha -Ca3(PO4)2]and/or tetracalcium phosphate [Ca4(PO4)2O] as an essential component and the hardening liquid comprises at least one acid selected from inorganic acids and acetic acid.
Hardening materials for medical and dental use, comprising a powder of calcium phosphate, a hardening liquid and at least one of collagen and a collagen derivative, wherein said calcium phosphate powder is composed of a powder of at least one of α-tricalcium phosphate and tetracalcium phosphate, said hardening liquid is a solution of at least one acid selected from inorganic acids and acetic acid, and wherein said collagen and collagen derivatives are in a non-fibrillar state and are selected from those which require eight minutes or more to undergo fibrillation under physiological conditions.
Claim 2
Dependent Claim
93 words
Hardening materials for medical and dental use, comprising a powder of calcium phosphate, a hardening liquid and at least one of collagen and a collagen derivative, wherein said calcium phosphate powder is composed of a powder of at least one of α-tricalcium phosphate and tetracalcium phosphate, said hardening liquid is a solution of at least one acid selected from inorganic acids and acetic acid, and wherein said collagen and collagen derivatives are in a non-fibrillar state and are selected from those which require eight minutes or more to undergo fibrillation under physiological conditions.